Valuation: Gulf Pharmaceutical Industries

Market Cap 1.07B 291M 261M 240M 217M 406M 27.62B 414M 2.86B 1.15B 14.53B 1.09B 45.82B P/E 2026 *
-
P/E 2027 * 7.12x
Enterprise Value 899M 245M 219M 202M 183M 341M 23.23B 348M 2.4B 965M 12.22B 918M 38.53B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.67x
Free-Float
34.75%
Yield 2026 *
-
Yield 2027 * -
1 day-2.43%
1 week-1.39%
Current month-10.19%
1 month-11.06%
3 months-11.06%
6 months-11.90%
Current year-20.94%
1 week 0.92
Extreme 0.92
1.01
1 month 0.91
Extreme 0.91
1.07
Current year 0.91
Extreme 0.91
1.26
1 year 0.91
Extreme 0.91
1.47
3 years 0.73
Extreme 0.73
1.78
5 years 0.7
Extreme 0.701
2.04
10 years 0.7
Extreme 0.701
4.51
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 01/01/2017
Director/Board Member - 01/01/2019
Chairman - 01/01/2005
Change 5-day change 1-year change 3-year change Capi.($)
-2.43%-1.39%-24.18%+23.17% 298M
+3.03%+10.82%+67.11%+149.46% 1,224B
-0.46%+3.92%+45.01%+86.46% 662B
+1.05%+2.86%+28.75%+107.07% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.67%+2.98%+73.39%+45.70% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.43%+6.07%+59.56%+77.02% 249B
+3.67%+9.74%+44.58%+120.19% 205B
Average +1.71%+2.44%+39.49%+77.09% 417.71B
Weighted average by Cap. +1.93%+3.04%+50.74%+97.94%

Financials

2026 *2027 *
Net sales 1.15B 314M 281M 258M 234M 438M 29.78B 446M 3.08B 1.24B 15.66B 1.18B 49.4B 1.24B 338M 303M 278M 252M 471M 32.08B 480M 3.32B 1.33B 16.88B 1.27B 53.22B
Net income 99M 26.95M 24.14M 22.2M 20.12M 37.61M 2.56B 38.31M 265M 106M 1.35B 101M 4.25B 148M 40.29M 36.09M 33.19M 30.08M 56.22M 3.83B 57.27M 396M 159M 2.01B 151M 6.35B
Net Debt -170M -46.28M -41.45M -38.13M -34.55M -64.58M -4.39B -65.79M -455M -183M -2.31B -174M -7.29B -232M -63.16M -56.57M -52.03M -47.15M -88.13M -6B -89.78M -621M -249M -3.15B -237M -9.95B
Projected Income Statement - Annual - Gulf Pharmaceutical Industries
Logo Gulf Pharmaceutical Industries
Gulf Pharmaceutical Industries Julphar Co PJSC is a United Arab Emirates based pharmaceutical company. The Company is engaged in manufacturing and selling of medicines, drugs and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The Company’s segments include Manufacturing, Planet, Investments. The products of the Company include general medicines, diabetes solutions, cardiovascular care, consumer healthcare products, wound care and dermatology, respiratory and git medicines. The Company’s subsidiaries include mena cool transportation f.z.e., julphar pharmaceuticals p.l.c., julphar ses l.l.c., diabtec l.l.c and others.
Employees
2,400
Date Price Change Volume
30/10/26 AED 0.9250 -2.43% 1,320,789
29/10/26 AED 0.9480 -0.94% 878,410
28/10/26 AED 0.9570 -1.34% 187,968
27/10/26 AED 0.9700 +2.11% 1,123,677
26/10/26 AED 0.9500 +3.26% 1,776,722
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Gulf Pharmaceutical Industries
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9250AED
Average target price
1.720AED
Spread / Average Target
+85.95%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Gulf Pharmaceutical Industries
  1. Stock Market
  2. Stocks
  3. JULPHAR Stock